123 related articles for article (PubMed ID: 1887382)
1. Ovarian carcinoma metastatic to the breast and axillary node.
Duda RB; August CZ; Schink JC
Surgery; 1991 Sep; 110(3):552-6. PubMed ID: 1887382
[TBL] [Abstract][Full Text] [Related]
2. Patients with a history of epithelial ovarian cancer presenting with a breast and/or axillary mass.
Karam AK; Stempel M; Barakat RR; Morrow M; Gemignani ML
Gynecol Oncol; 2009 Mar; 112(3):490-5. PubMed ID: 19101713
[TBL] [Abstract][Full Text] [Related]
3. Metastasis of breast carcinoma to a primary mucinous cystadenocarcinoma of the ovary.
Twaalfhoven FC; Fleuren GJ; Cornelisse CJ; Peters AA; Trimbos JB; Hogendoorn PC
Gynecol Oncol; 1994 Jan; 52(1):80-6. PubMed ID: 8307506
[TBL] [Abstract][Full Text] [Related]
4. Breast metastasis 56 months before the diagnosis of primary ovarian cancer: a case study.
Schneuber SE; Scholz HS; Regitnig P; Petru E; Winter R
Anticancer Res; 2008; 28(5B):3047-50. PubMed ID: 19031954
[TBL] [Abstract][Full Text] [Related]
5. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of flow cytometry for metastatic potential in breast cancer.
Schmidt H; Wei JP; Yeh KA
Am Surg; 1999 May; 65(5):434-8. PubMed ID: 10231212
[TBL] [Abstract][Full Text] [Related]
7. A significant correlation between nuclear CXCR4 expression and axillary lymph node metastasis in hormonal receptor negative breast cancer.
Woo SU; Bae JW; Kim CH; Lee JB; Koo BW
Ann Surg Oncol; 2008 Jan; 15(1):281-5. PubMed ID: 17763975
[TBL] [Abstract][Full Text] [Related]
8. Metastatic breast cancer from gastric and ovarian cancer, mimicking inflammatory breast cancer: report of two cases.
Sato T; Muto I; Fushiki M; Hasegawa M; Hasegawa M; Sakai T; Sekiya M
Breast Cancer; 2008; 15(4):315-20. PubMed ID: 18311479
[TBL] [Abstract][Full Text] [Related]
9. Correlation of DNA flow cytometry and hormone receptors with axillary lymph node status in patients with carcinoma of the breast.
Friedman NS; Freedman MD
Md Med J; 1994 Nov; 43(11):963-5. PubMed ID: 7808198
[TBL] [Abstract][Full Text] [Related]
10. Axillary lymph node metastasis from serous ovarian cancer: a case report and review of the literature.
Aydin C; Unalp HR; Baloğlu A; Inci AG; Yiğit S; Yavuzcan A
Arch Gynecol Obstet; 2009 Feb; 279(2):203-7. PubMed ID: 18470522
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of occult axillary lymph node metastases after chemotherapy-induced pathologic complete response of cytologically proven axillary lymph node metastases from breast cancer.
Loya A; Guray M; Hennessy BT; Middleton LP; Buchholz TA; Valero V; Sahin AA
Cancer; 2009 Apr; 115(8):1605-12. PubMed ID: 19197997
[TBL] [Abstract][Full Text] [Related]
12. Occult breast cancer presenting as axillary metastases.
Yamaguchi H; Ishikawa M; Hatanaka K; Uekusa T; Ishimaru M; Nagawa H
Breast; 2006 Apr; 15(2):259-62. PubMed ID: 15996865
[TBL] [Abstract][Full Text] [Related]
13. Ovarian pathology in risk-reducing salpingo-oophorectomies from women with BRCA mutations, emphasizing the differential diagnosis of occult primary and metastatic carcinoma.
Rabban JT; Barnes M; Chen LM; Powell CB; Crawford B; Zaloudek CJ
Am J Surg Pathol; 2009 Aug; 33(8):1125-36. PubMed ID: 19440148
[TBL] [Abstract][Full Text] [Related]
14. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
[TBL] [Abstract][Full Text] [Related]
15. Metastatic ovarian serous carcinoma presenting as inflammatory breast cancer: a case report.
Gingell D; Samuel A; Haynik D; McBee W; Kelley J; Zorn K; Bhargava R
Int J Gynecol Pathol; 2010 May; 29(3):243-7. PubMed ID: 20407323
[TBL] [Abstract][Full Text] [Related]
16. Prediction of additional axillary metastasis of breast cancer following sentinel lymph node surgery.
Changsri C; Prakash S; Sandweiss L; Bose S
Breast J; 2004; 10(5):392-7. PubMed ID: 15327491
[TBL] [Abstract][Full Text] [Related]
17. Bilateral metastatic carcinoma of the breast from primary ovarian cancer.
Ozsaran AA; Dikmen Y; Terek MC; Ulukus M; Ozdemir N; Orgüc S; Erhan Y
Arch Gynecol Obstet; 2000 Nov; 264(3):166-7. PubMed ID: 11129521
[TBL] [Abstract][Full Text] [Related]
18. Breast mass in a patient with ovarian cancer: a case report.
Gayathri S; Badve S; Matei D
J Reprod Med; 2009 Oct; 54(10):639-44. PubMed ID: 20677485
[TBL] [Abstract][Full Text] [Related]
19. Impact of metastatic estrogen receptor and progesterone receptor status on survival.
Lower EE; Glass EL; Bradley DA; Blau R; Heffelfinger S
Breast Cancer Res Treat; 2005 Mar; 90(1):65-70. PubMed ID: 15770528
[TBL] [Abstract][Full Text] [Related]
20. Prediction of axillary lymph node status of breast cancer patients by tumorbiological factors of the primary tumor.
Fehm T; Maul H; Gebauer S; Scharf A; Baier P; Sohn C; Jäger W; Gebauer G
Strahlenther Onkol; 2005 Sep; 181(9):580-6. PubMed ID: 16170485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
